Cause of death, by non-communicable diseases, ages 0-4, male in Algeria
Algeria: Cause of death, by non-communicable diseases, ages 0-4, male was 24.3% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, male in Algeria, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4, male in Algeria stood at 24.3%.
That represents a change of down 1.3% on the previous year and up 10.7% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, male in Algeria peaked at 25.6% in 2015 and was at its lowest, 16.0%, in 2000.
That places Algeria 114th out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 0-4, male in Algeria, year by year
| Year | % of total male deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 16.0% | — |
| 2010 | 21.9% | +36.9% |
| 2015 | 25.6% | +16.6% |
| 2019 | 24.4% | -4.6% |
| 2020 | 24.6% | +0.7% |
| 2021 | 24.3% | -1.3% |
Algeria compared with similar countries
- Algeria's 24.3% is below the median for upper middle income countries, which is 31.9%, 76% of the median. (55 countries reporting)
- Algeria's 24.3% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 35.4%, 69% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 16.0% | 16.0% | 16.0% | 1 |
| 2010s | 24.0% | 21.9% | 25.6% | 3 |
| 2020s | 24.4% | 24.3% | 24.6% | 2 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0465 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, male in Algeria?
- Cause of death, by non-communicable diseases, ages 0-4, male in Algeria was 24.3% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, male recorded in Algeria?
- The highest recorded value was 25.6% in 2015.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, male recorded in Algeria?
- The lowest recorded value was 16.0% in 2000.
- How does Algeria rank for cause of death, by non-communicable diseases, ages 0-4, male?
- Algeria ranks 114th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, male rising or falling in Algeria?
- Over the last ten years it is up 10.7%. The long-run trend across the full record is rising.
- Where does this Algeria data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.